COMP <GO>
ARVN vs GYRE // 10Y YIELD & FRED MACRO BETA
Arvinas Inc. (NASDAQ) VS. Gyre Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: ARVN 2
— GYRE 6
■ METRIC PARITY
LAST: $7.52 (-4.33%) • MKT CAP: $513.9M
macro-sensitivity
—
LAST: $4.73 (+3.84%) • MKT CAP: $507.9M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARVN VS. GYRE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ARVN | GYRE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 95.40% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -32.10% | 25.40% | -57.50 | GYRE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 53.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -0.03% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -45.10% | 9.90% | -55.00 | GYRE | /operating-margins <GO> |
| Net Profit Margin | -30.80% | 8.50% | -39.30 | GYRE | /net-margins <GO> |
| Revenue Growth (YoY) | -0.30% | 10.20% | -10.50 | GYRE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 14.33 | -14.13 | GYRE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 5/9 | -2.00 | GYRE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.4 | 38.0 | +16.40 | ARVN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 67.2x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $513.9M | $507.9M | $6.0M | ARVN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ARVN REV | GYRE REV | ARVN GROSS % | GYRE GROSS % | ARVN FCF | GYRE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $262.6M | $116.6M | — | 95.4% | -$275.7M | -$180.0K |
| FY 2024 | $263.4M | $105.8M | — | 96.3% | -$261.1M | -$6.0M |
| FY 2023 | $78.5M | $113.5M | — | — | -$347.8M | $25.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARVN // BETA —
GYRE // BETA —